NanoSyrinx, a synthetic biology company developing nanosyringes, announced that it closed a £10 million ($13 million) financing round. BGF, Octopus Ventures and M Ventures led the financing. Existing investors IQ Capital and Meltwind also participated. According to a news release, pharmaceutical giant Eli Lilly took part in the funding round as well. NanoSyrinx also named […]